358
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

ECT augmentation of antipsychotics in severely ill schizophrenia: a naturalistic, observational study

, ORCID Icon, ORCID Icon &
Pages 392-397 | Received 17 Mar 2020, Accepted 27 May 2020, Published online: 15 Jun 2020

References

  • Agarwal A, Winny GC. 1985. Role of ECT phenothiazine combination in schizophrenia. Indian J Psychiatry. 27:233–236.
  • Ahmed S, Khan AM, Mekala HM, Venigalla H, Ahmed R, Etman A, Esang M, Qureshi M. 2017. Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: a comparative meta-analysis. Heliyon. 3:e00429. doi:10.1016/j.heliyon.2017.e00429
  • Ali SA, Mathur N, Malhotra AK, Braga RJ. 2019. Electroconvulsive therapy and schizophrenia: a systematic review. Mol Neuropsychiatry. 5:75–83. doi:10.1159/000497376
  • American Psychiatric Association. 2000. Diagnostic and statisitcal manual of mental disorders. 4th ed., text revision. Washington (DC): American Psychiatric Association.
  • American Psychiatric Association. 2008. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (A Task Force Report of the American Psychiatric Association). Washington (DC): American Psychiatric Association Publishing.
  • Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R. 2014. Neurotransmitters and electroconvulsive therapy. J ECT. 30:116–121. doi:10.1097/YCT.0000000000000138
  • Biedermann F, Pfaffenberger N, Baumgartner S, Kemmler G, Fleischhacker WW, Hofer A. 2011. Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes. J Ect. 27:e61–e62. doi:10.1097/YCT.0b013e31821a8f05
  • Chanpattana W, Chakrabhand ML, Buppanharun W, Sackeim HA. 2000. Effects of stimulus intensity on the efficacy of bilateral ECT in schizophrenia: a preliminary study. Biol Psychiatry. 48:222–228. doi:10.1016/S0006-3223(00)00830-1
  • Chanpattana W, Chakrabhand ML. 2001. Factors influencing treatment frequency of continuation ECT in schizophrenia. J ECT. 17:190–194. doi:10.1097/00124509-200109000-00008
  • Chanpattana W, Kramer BA. 2003. Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes. Schizophr Res. 63:189–193. doi:10.1016/S0920-9964(02)00330-4
  • Elkis H, Buckley PF. 2016. Treatment-resistant schizophrenia. Psychiatr Clin North Am. 39:239–265. doi:10.1016/j.psc.2016.01.006
  • Endler NS. 1988. The origins of electroconvulsive therapy (ECT). Convuls Ther. 4:5–23.
  • Goswami U, Kumar U, Singh B. 2003. Efficacy of electroconvulsive therapy in treatment resistant schizophreinia: a double-blind study. Indian J Psychiatry. 45:26–29.
  • Grover S, Chakrabarti S, Hazari N, Avasthi A. 2017. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: a retrospective study. Psychiatry Res. 249:349–353. doi:10.1016/j.psychres.2017.01.042
  • Hirose S, Ashby CR, Jr., Mills MJ. 2001. Effectiveness of ECT combined with risperidone against aggression in schizophrenia. J ECT. 17:22–26. doi:10.1097/00124509-200103000-00005
  • Hustig H, Onilov R. 2009. ECT rekindles pharmacological response in schizophrenia. Eur Psychiatry. 24:521–525. doi:10.1016/j.eurpsy.2009.04.005
  • Kartalci S, Karabulut AB, Erbay LG, Acar C. 2016. Effects of electroconvulsive therapy on some inflammatory factors in patients with treatment-resistant schizophrenia. J ECT. 32:174–179. doi:10.1097/YCT.0000000000000303
  • Kaster TS, Daskalakis ZJ, Blumberger DM. 2017. Clinical effectiveness and cognitive impact of electroconvulsive therapy for schizophrenia: a large retrospective study. J Clin Psychiatry. 78:e383–e389. doi:10.4088/JCP.16m10686
  • Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13:261–276. doi:10.1093/schbul/13.2.261
  • Kho KH, Blansjaar BA, de Vries S, Babuskova D, Zwinderman AH, Linszen DH. 2004. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia-an open label study. Eur Arch Psychiatry Clin Neurosci. 254:372–379. doi:10.1007/s00406-004-0517-y
  • Kristensen D, Bauer J, Hageman I, Jørgensen MB. 2011. Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas. Eur Arch Psychiatry Clin Neurosci. 261:425–432. doi:10.1007/s00406-010-0173-3
  • Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M. 2000. Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol. 23:14–16. doi:10.1097/00002826-200001000-00003
  • Lally J, Tully J, Robertson D, Stubbs B, Gaughran F, MacCabe JH. 2016. Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-analysis. Schizophr Res. 171:215–224. doi:10.1016/j.schres.2016.01.024
  • Leucht S, Kissling W, Davis JM. 2010. The PANSS should be rescaled. Schizophr Bull. 36:461–462. doi:10.1093/schbul/sbq016
  • Leucht S. 2014. Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application. J Clin Psychiatry. 75 Suppl 1:8–14. doi:10.4088/JCP.13049su1c.02
  • Li J, Ye F, Xiao W, Tang X, Sha W, Zhang X, Wang J. 2016. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia. Eur Psychiatr. 36:23–28. doi:10.1016/j.eurpsy.2016.03.005
  • Lin HT, Liu SK, Hsieh MH, Chien YL, Chen IM, Liao SC, Tsai HJ, Wu CS. 2018. Impacts of electroconvulsive therapy on 1-year outcomes in patients with schizophrenia: a controlled, population-based mirror-image study. Schizophr Bull. 44:798–806. doi:10.1093/schbul/sbx136
  • Masoudzadeh A, Khalilian AR. 2007. Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients. Pakistan J Biol Sci. 10:4287–4290. doi:10.3923/pjbs.2007.4287.4290
  • Nothdurfter C, Eser D, Schüle C, Zwanzger P, Marcuse A, Noack I, Möller HJ, Rupprecht R, Baghai TC. 2006. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 7:162–170. doi:10.1080/15622970500395280
  • Obermeier M, Mayr A, Schennach-Wolff R, Seemüller F, Möller HJ, Riedel M. 2010. Should the PANSS be rescaled? Schizophr Bull. 36:455–460. doi:10.1093/schbul/sbp124
  • Painuly N, Chakrabarti S. 2006. Combined use of electroconvulsive therapy and antipsychotics in schizophrenia: the Indian evidence. A review and a meta-analysis. J Ect. 22:59–66. doi:10.1097/00124509-200603000-00013
  • Pawelczyk T, Kolodziej-Kowalska E, Pawelczyk A, et al. 2014. Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms. Psychiatry Res. 220:175–180. doi:10.1016/j.psychres.2014.07.071
  • Petrides G, Malur C, Braga RJ, Bailine SH, Schooler NR, Malhotra AK, Kane JM, Sanghani S, Goldberg TE, John M, et al. 2015. Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study. AJP. 172:52–58. doi:10.1176/appi.ajp.2014.13060787
  • Pompili M, Lester D, Dominici G, Longo L, Marconi G, Forte A, Serafini G, Amore M, Girardi P. 2013. Indications for electroconvulsive treatment in schizophrenia: a systematic review. Schizophr Res. 146:1–9. doi:10.1016/j.schres.2013.02.005
  • Rosenquist PB, Miller B, Pillai A. 2014. The antipsychotic effects of ECT: a review of possible mechanisms. J ECT. 30:125–131. doi:10.1097/YCT.0000000000000131
  • Sanghani SN, Petrides G, Kellner CH. 2018. Electroconvulsive therapy (ECT) in schizophrenia: a review of recent literature. Curr Opin Psychiatry. 31:213–222. doi:10.1097/YCO.0000000000000418
  • Takacs R, Ivanyi Z, Ungvari GS, et al. 2013. Safety of the electroconvulsive therapy and amisulpride combination. Psychiatr Danub. 25:76–79.
  • Tharyan P, Adams CE. 2005. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. CD000076.
  • Wang G, Zheng W, Li XB, Wang SB, Cai DB, Yang XH, Ungvari GS, Xiang YT, Correll CU. 2018. ECT augmentation of clozapine for clozapine-resistant schizophrenia: a meta-analysis of randomized controlled trials. J Psychiatr Res. Oct. 105:23–32. doi:10.1016/j.jpsychires.2018.08.002
  • Yagcioglu AB, Tiryaki A, Gogus A. 1999. The reliability and validity of Turkish version of positive and negative symptom scale (PANSS). Turk Psikoloji Dergisi. 14:23–34.
  • Zheng W, Cao XL, Ungvari GS, Xiang YQ, Guo T, Liu ZR, Wang YY, Forester BP, Seiner SJ, Xiang YT, et al. 2016. Electroconvulsive therapy added to non-clozapine antipsychotic medication for treatment resistant schizophrenia: meta-analysis of randomized controlled trials. PLoS One. 11:e0156510. doi:10.1371/journal.pone.0156510

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.